Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,946 GBX | -1.39% | -2.95% | +8.61% |
May. 17 | HIKMA PHARMACEUTICALS : Time to capitalise on Hikma’s ongoing (share price) momentum | |
May. 03 | Deutsche Bank Starts Hikma Pharmaceuticals Coverage at Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.61% | 5.56B | |
+38.43% | 705B | |
+32.30% | 583B | |
-2.86% | 364B | |
+21.10% | 332B | |
+6.39% | 291B | |
+15.92% | 238B | |
-3.48% | 210B | |
+10.50% | 209B | |
+9.76% | 169B |
- Stock Market
- Equities
- HIK Stock
- News Hikma Pharmaceuticals PLC
- Hikma's Generics Recovery Remains Uncertain Despite Upgraded Outlook, Berenberg Says